Age-related macular degeneration (AMD), a multifactorial human disorder, is the most common cause of acquired visual impairment in people over the age 60. It is estimated to affect millions of individuals worldwide. Prevalence increases with age; among persons 75 years and older, mild, or early forms occur in nearly 30% and advanced forms in about 7% of the population. AMD has been associated both with environmental and genetic factors. However, the clinical heterogeneity, late age at onset, and complex etiology have confounded genetic studies of the disorder. Methods applicable to the study of single-gene and some complex disorders (i.e., linkage analysis, sib-pair analysis, transmission disequilibrium test, etc.) have had limited utility in elucidating the genetic components of the complex AMD trait.
Recently, substantial progress has been made in determining the genetic basis of monogenic eye disorders. On a monthly basis mutations are identified in new genes responsible for some form of retinal degeneration. Most, if not all, of these genes become candidates for potential involvement in multifactorial disorders especially if the phenotypes of the early-onset Mendelian diseases they cause resemble later onset complex traits. Unfortunately, to date mutational analyses of the candidate genes in AMD patients to date have not yielded the highly anticipated information: statistically significant association of sequence variants with AMD. Whether this is due to the unsuccessful selection of the right candidate genes for the analysis, or the methods employed, or both, has to be elucidated.
This review summarizes current knowledge of genetic research aimed at delineating the molecular genetic basis of age-related macular degeneration. Moreover, it attempts to offer some approaches for the future studies directed towards understanding the genetic components of this complex disorder.
SeddonJ.M., AjaniU.A., SperdutoR.D.Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.JAMA1994; 272: 1413–20.
2.
SeddonJ.M., WillettW.C., SpeizerF.E.A prospective study of cigarette smoking and age-related macular degeneration in women.JAMA1996; 276: 1141–6.
3.
SmithW., MitchellP., LeederS.R.. Smoking and age-related maculopathy. The Blue Mountains Eye Study.Arch Ophthalmol1996; 114: 1518–23.
4.
MitchellP., SmithW., WangJ.J.. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study.Ophthalmology1998; 105: 1359–63.
5.
VandenLangenbergG.M., Mares-PerlmanJ.A., KleinR.Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study.Am J Epidemiol1998; 148: 204–14.
6.
Mares-PerlmanJ.A., BradyW.E., KleinR.Dietary fat and age-related maculopathy.Arch Ophthalmol1995; 113: 743–8.
7.
HirvelaH., LuukinenH., LaaraE.Risk factors of age-related maculopathy in a population 70 years of age or older.Ophthalmology1996; 103: 871–7.
8.
KleinM.L., MauldinW.M., StoumbosV.D.. Heredity and age-related macular degeneration. Observations in monozygotic twins.Arch Ophthalmol1994; 112: 932–7.
9.
HeibaI.M., ElstonR.C., KleinB.E.Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study.Genet Epidemiol1994; 11: 51–67.
KleinR., KleinB.E., LintonK.L.. Prevalence of age-related maculopathy. The Beaver Dam Eye Study.Ophthalmology1992; 99: 933–43.
14.
VingerlingJ.R., DielemansI., HofmanA.The prevalence of age-related maculopathy in the Rotterdam Study.Ophthalmology1995; 102: 205–10.
15.
RosenbergT., KlieF.. The incidence of registered blindness caused by age-related macular degeneration.Acta Ophthalmol Scand1996; 74: 399–402.
16.
EvansJ., WormaldR.. Is the incidence of registrable age-related macular degeneration increasing?Br J Ophthalmol1996; 80: 9–14.
17.
CruickshanksK.J., HammanR.F., KleinR.The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy.Arch Ophthalmol1997; 115: 242–50.
18.
KleinR., KleinB.E., JensenS.C.Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III.Ophthalmology1999; 106: 1056–65.
BirdA.C., BresslerN.M., BresslerS.B.An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.Surv Ophthalmol1995; 39: 367–74.
21.
SunnessJ.S., Gonzalez-BaronJ., BresslerN.M.The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration.Ophthalmology1999; 106: 910–9.
22.
SeddonJ.M., SamelsonL.J., PageW.F.Twin study of macular degeneration: methodology and application to genetic epidemiologic studies.Invest Ophthalmol Vis Sci1997; 38(suppl): S676.
23.
CurcioC.A., MedeirosN.E., MillicanC.L.. The Alabama Age-Related Macular Degeneration Grading System for donor eyes.Invest Ophthalmol Vis Sci1998; 39: 1085–96.
24.
The Age-Related Eye Disease Study (AREDS):Design Implications.Control Clin Trials1999; (in press).
O'DonovanM.C., OwenM.J.. Candidate-gene association studies of schizophrenia.Am J Hum Genet1999; 65: 587–92.
27.
KleinM.L., SchultzD.W., EdwardsA.Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q.Arch Ophthalmol1998; 116: 1082–8.
28.
RischN., MerikangasK.. The future of genetic studies of complex human diseases.Science1996; 273: 1516–7.
29.
SpielmanR.S., McGinnisR.E., EwensW.J.. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).Am J Hum Genet1993; 52: 506–16.
30.
WeberB.H., VogtG., PruettR.C.Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.Nat Genet1994; 8: 352–6.
31.
AndreuT., BeckersT., ThoenesE.Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type 1 alpha2 (COL1a2) are epidermal growth factor-regulated growth repressors.J Biol Chem1998; 273: 13848–54.
32.
FelborU., DoepnerD., SchneiderU.Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.Invest Ophthalmol Vis Sci1997; 38: 1054–9.
33.
De La PazM.A., Pericak-VanceM.A., LennonF.Exclusion of TIMP3 as a candidate locus in age-related macular degeneration.Invest Ophthalmol Vis Sci1997; 38: 1060–5.
34.
PetrukhinK., KoistiM.J., BakallB.Identification of the gene responsible for Best macular dystrophy.Nat Genet1998; 19: 241–7.
35.
MarquardtA., StohrH., PassmoreL.A.Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease).Hum Mol Genet1998; 7: 1517–25.
36.
AllikmetsR., SeddonJ.M., BernsteinP.S.Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies.Hum Genet1999; 104: 449–53.
37.
StoneE.M., LoteryA.J., MunierF.L.A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.Nat Genet1999; 22: 199–202.
38.
IkegawaS., TodaT., OkuiK.Structure and chromosomal assignment of the human S1-5 gene (FBNL) that is highly homologous to fibrillin.Genomics1996; 35: 590–2.
39.
AllikmetsR., SinghN., SunH.A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy (see comments).Nat Genet1997; 15: 236–46.
40.
Martinez-MirA., PalomaE., AllikmetsR.Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR (letter; comment).Nat Genet1998; 18: 11–2.
41.
CremersF.P., van de PolD.J., van DrielM.Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR.Hum Mol Genet1998; 7: 355–62.
42.
AllikmetsR., ShroyerN.F., SinghN.Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.Science1997; 277: 1805–7.
43.
StoneE.M., WebsterA.R., VandenburghK.Allelic variation in ABCR associated with Stargardt disease but not age- related macular degeneration.Nat Genet1998; 20: 328–9.
44.
KuroiwaS., KojimaH., KikuchiT.ATP binding cassette transporter retina genotypes and age related macular degeneration: an analysis on exudative non-familial Japanese patients.Br J Ophthalmol1999; 83: 613–5.
45.
De La PazM.A., GuyV.K., Abou-DoniaS.Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration.Ophthalmology1999; 106: 1531–6.
46.
LewisR.A., ShroyerN.F., SinghN.Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease.Am J Hum Genet1999; 64: 422–34.
47.
MaugeriA., van DrielM.A., van de PolD.J.The 2588G—>C mutation in the ABCR gene is a mild frequent founder mutation in the western european population and allows the classification of ABCR mutations in patients with stargardt disease.Am J Hum Genet1999; 64: 1024–35.
48.
FishmanG.A., StoneE.M., GroverS.Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene.Arch Ophthalmol1999; 117: 504–10.
49.
LongA.D., LangleyC.H.. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits.Genome Res1999; 9: 720–31.
50.
AllikmetsR., HutchinsonA., LewisR.A.Association of G1961E and D2177N variants in the ABCR gene with age-related macular degeneration (ARVO Abstract).Invest Ophthalmol Vis Sci1999; 40(suppl): S775.
51.
van DrielM.A., MaugeriA., KleveringB.J.ABCR unites what ophthalmologists divide(s).Ophthalmic Genet1998; 19: 117–22.
52.
ShroyerN.F., LewisR.A., AllikmetsR.The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial.Vision Res1999; 39: 2537–44.
53.
SimonelliF., TestaF., de CrecchioG.New ABCR mutations and clinical phenotype in Italian patients with Stargardt disease.Invest Ophthalmol Vis Sci1999 (in press).
54.
SouiedE.H., DucroqD., GerberS.Age-related macular degeneration in grandparents of patients with Stargardt disease: genetic study.Am J Ophthalmol1999; 128: 173–8.
55.
SunH., NathansJ.. Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments.Nat Genet1997; 17: 15–6.
56.
SunH., MoldayR.S., NathansJ.. Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease.J Biol Chem1999; 274: 8269–81.
57.
WengJ., MataN.L., AzarianS.M.Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice.Cell1999; 98: 13–23.
58.
ZhangK., KniazevaM., HutchinsonA.The ABCR gene in recessive and dominant stargardt diseases: A genetic pathway in macular degeneration.Genomics1999; 60: 234–7.
59.
MarlhensF., BareilC., GriffoinJ.M.Mutations in RPE65 cause Leber's congenital amaurosis.Nat Genet1997; 17: 139–41.
60.
GuS.M., ThompsonD.A., SrikumariC.R.Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy.Nat Genet1997; 17: 194–7.
61.
KniazevaM., ChiangM.F., MorganB.A new locus for autosomal dominant stargardt-like disease maps to chromosome 4.Am J Hum Genet1999; 64: 1394–9.
62.
NicholsB.E., SheffieldV.C., VandenburghK.Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene.Nat Genet1993; 3: 202–7.
63.
WellsJ., WroblewskiJ., KeenJ.Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy.Nat Genet1993; 3: 213–8.
64.
FelborU., SchillingH., WeberB.H.. Adult vitelliform macular dystrophy is frequently associated with mutations in the peripherin/RDS gene.Hum Mutat1997; 10: 301–9.
65.
StoneE.M., NicholsB.E., KimuraA.E.Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q.Arch Ophthalmol1994; 112: 765–72.
66.
KelsellR.E., Gregory-EvansK., Gregory-EvansC.Y.Localization of a gene (CORD7) for a dominant cone-rod dystrophy to chromosome 6q.Am J Hum Genet1998; 63: 274–9.
67.
SmallK.W., WeberJ., RosesA.North Carolina macular dystrophy (MCDR1). A review and refined mapping to 6q14-q16.2.Ophthalmic Paediatr Genet1993; 14: 143–50.
68.
KelsellR.E., GodleyB.F., EvansK.Localization of the gene for progressive bifocal chorioretinal atrophy (PBCRA) to chromosome 6q.Hum Mol Genet1995; 4: 1653–6.
69.
SmallK.W., SyrquinM., MullenL.Mapping of autosomal dominant cone degeneration to chromosome 17p.Am J Ophthalmol1996; 121: 13–8.
